Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025

Core Viewpoint - Ascendis Pharma A/S will report its second quarter 2025 financial results and provide a business update on August 7, 2025, after U.S. market close, followed by a conference call and live webcast to discuss the results [1]. Company Overview - Ascendis Pharma is a global biopharmaceutical company that utilizes its innovative TransCon technology platform to develop new therapies aimed at addressing unmet medical needs [3]. - The company is headquartered in Copenhagen, Denmark, with additional facilities in Europe and the United States [3]. Event Details - The live webcast for the financial results discussion can be accessed through the company's website, and a replay will be available for 30 days post-event [2].